Vetter News

News
New clinical manufacturing site now integrated

After only one year our location in Austria has been modified to the high Vetter quality standards.

Read more

CDMO Insights
Clinical manufacturing on time and within budget

The key to successful development and guiding a drug to approval is early planning.

Read more

CDMO Insights
ID determination of oligonucleotides

Fast, safe and efficient: the new Vetter ID determination of oligonucleotides.

Read more

Careers
Vetter is a “Great place to work”

92 percent of our colleagues in Chicago named Vetter a “Great Place to Work” company!

Read more

News
Innovation and Responsibility for Patients

In this article Senior Vice President Kai Vogt talks about the opportunities of digital transformation at Vetter.

Read more

News
Axia Best Managed Companies Award

Renewed award confirms continuity and the approach to sustainability.

Read more

Vetter and Rentschler Biopharma Further Strengthen their Strategic Alliance

Rentschler Biopharma and Vetter announced today that their strategic collaboration has taken key steps forward.

Read more

CDMO Insights
Vetter’s strategic growth in APAC

Interview with Oskar Gold, SVP Asia Pacific and Global Emerging Markets

Read more

25 Aug
Events
Gusu Dialogue
25.08.21 - 27.08.21 | Suzhou, China

A conference organized by China National Pharmaceutical Package Association

Read more

31 Aug
Events
Bioplus Interphex Korea
31.08.21 - 02.09.21 | COEX, Seoul

BIOplus is a global Bio event with high quality of conference, exhibition, business partnering since 2015.

Read more

20 Sep
Events
TIDES: Oligonucleotide & Peptide Therapeutics
20.09.21 - 23.09.21 | Boston, USA

The largest meeting to accelerate oligunucleotide and peptide products from discovery to commercialization.

Read more